Navigation Links
Medco Unveils Three New Medicare Prescription Drug Plan Options for 2008 to Provide Seniors More Choice, Better Value and Specialist Pharmacists
Date:10/1/2007

Generics covered in the Coverage Gap, $2 for 30-day supply of generics

redefines value for seniors

Medco Medicare Plan Provides "Specialist Pharmacists" experienced in medications used to treat common chronic conditions that affect seniors

FRANKLIN LAKES, N.J., Oct. 1 /PRNewswire-FirstCall/ -- Many seniors recall the days when a dime could buy quite a bit. While a dime can't buy much anymore, for millions of seniors across the country, it could potentially pay for a day's worth of their medications.

Medco Health Solutions, Inc. (NYSE: MHS), today unveiled the Medco Medicare Prescription Plan(TM), a suite of three new Medicare Part D plan options for 2008 that offers seniors a range of deductible, plan and coverage options for their prescription drug needs.

The new Medco Medicare Prescription Plan portfolio consists of the following:

-- Access plan, a $0 deductible plan with copays for chronic medications

available for as little as $2 for a 30-day supply (when purchasing a

90-day supply of a generic medication via mail), and generics coverage

in the coverage gap;

-- Choice plan, which features a $0 deductible, $2 for a 30-day supply

(when purchasing a 90-day supply of a generic medication via mail), and

access to more than 3,400 prescription drugs;

-- Value plan, a low premium plan with access to thousands of medications

including generic, brand name and specialty drugs.

"The needs of seniors vary greatly - from access to a wide range of medications to a low premium to coverage in the gap - and we've designed a range of plan options for seniors to select based upon their individual needs,"
'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Pfizer unveils anti-smoking drug
2. Study Unveils New Insight To The Madness Of King George III
3. Bush Unveils Latest Blueprint for Handling Bird Flu Pandemic
4. Rae unveils Health-care Strategy
5. Study Unveils West Nile Virus Immune Evasion, Points to Vaccine Development
6. Pesticides Linked to High Risk of Pediatric Cancers - a Study Unveils
7. Pet Owners Less Healthy: Study Unveils
8. Biocon Unveils Renal Therapies for Kidney Disorders
9. China Unveils Green Plan to Revert Farmland to Forest
10. Japanese Firm Unveils Artificial Hand With air Muscles
11. Boeing Unveils green Dreamliner Passenger Jet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...on models are enhanced by taking into account risk...ity, according to research teams led by epidemiolo...ncer Center in two complementary papers appearing ...rch . , In the first study to focus on African-A...n increased exposure to certain risks. Based upon ...
(Date:9/4/2008)...wswire/ -- A groundbreaking program,dealing with t...atus of,men, their shorter life spans, unmet gende...ke place Wednesday, September 17 at White Plains,H... of the Westchester,medical and psychiatric societ... and Lionel Tiger, Ph.D., Dr. Legatto, an interna...
(Date:9/4/2008)...ivate Medicare Advantage (MA) plans will be paid a...ompared to what the same enrollee would have cost ...m, according to a new report from The Commonwealth... mandated by the Medicare Improvements for Patient...take effect beginning in 2010 had been fully in p...
(Date:9/4/2008)...ns may be shortchanging their golden years by tapp...University of Illinois expert who has studied the ... , More than three of every four Americans trim ...laiming benefits early, a choice many might forego...nd consequences, law professor Richard L. Kaplan s...
Breaking Medicine News(10 mins):Health News:Creating lung cancer risk models for specific populations refines prediction 2Health News:Creating lung cancer risk models for specific populations refines prediction 3Health News:Extra payments to Medicare Advantage plans to total $8.5 billion in 2008 2Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3
... levels of stress experienced by children may hamp...n suffering from post-traumatic// stress disorder ... memory and emotion had become smaller in size. C...stress and anxiety when their hippocampus is shrun...
...in, say researchers at the Stanford University Sch...spital. The researchers found that children with p...he stress hormone cortisol were likely to experien...n structure important in memory processing and emo...
...on for health professionals must include teaching ...//cancer about sex, cancer experts say. Sexuality... want to discuss with their doctor or member of th...rn of the Cancer Council Victoria, and Dr Annette ...
...hat a new technique safely and effectively removes...t risk for pulmonary embolism and disability. Th...n to have a positive impact on patients’ quality o...in and swelling, as well as greatly improving thei...
Other Medicine News:Health News:Child Brain Likely To Be Harmed By Stress 2Health News:Severe PTSD Damages Children's Brains: Study 2Health News:Severe PTSD Damages Children's Brains: Study 3Health News:Sex After Cancer 2Health News:DVT Treatment Vacuums Away Blood Clots – Prevents Disabilit 2
(Date:9/4/2008)...- Southern Research Institute,today announced that...ted,the organization to participate in the newly-f...Network (MLPCN). The MLPCN -- a collaborative,rese... Program which is,designed to benefit human health... and validate future targets for drug discovery., ...
(Date:9/4/2008)...l activity and favorable safety .../- Idenix,Pharmaceuticals, ... engaged,in the discovery and development of drugs...ious diseases, today announced that it has complet... non-nucleoside reverse,transcriptase inhibitor (N...
(Date:9/3/2008)...ldren Studied. Wrong,Conclusions Reached., NIXA, ...for Disease,Control and Prevention (CDC) study rel...R vaccine and autism. The National Autism Associat...he growing public concern over a,vaccine-autism co...esign,and methodology., For years, parents have c...
(Date:9/3/2008)...sease Awareness Month, CHARLOTTESVILLE, Va., Sept... a clinical-stage drug-development company commerc...cal needs, announced today that it has begun,to en...s lead drug,candidate trans sodium crocetinate (TS...caltrials.gov Website, is investigating TSC as a t...
Breaking Medicine Technology:Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4CDC Misses Target With Flawed MMR/Autism Study 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Heat stress influences low conception of dairy herds 288 1Heat stress influences low conception of dairy herds 288 2Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision 3B Believes Offer Significantly Undervalues Company 666 1Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision 3B Believes Offer Significantly Undervalues Company 666 2Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision 3B Believes Offer Significantly Undervalues Company 666 3Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision 3B Believes Offer Significantly Undervalues Company 666 4Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision 3B Believes Offer Significantly Undervalues Company 666 5Youth Drug Use at a Five Year Low New Survey Shows 662 1Youth Drug Use at a Five Year Low New Survey Shows 662 2Youth Drug Use at a Five Year Low New Survey Shows 662 3Securians Minnesota Life Continues to Climb Group Life Rankings 658 1
...tudy Fails to Meet Primary Endpoint of Improvement... 2007 /PRNewswire-FirstCall/ --,Allos Therapeutics...H, the Company,s pivotal Phase 3 study of Efaproxy...y (WBRT) in women,with brain metastases originatin...its primary endpoint of demonstrating a,statistica...
...SAN DIEGO, June 20, 2007 /PRNewswire-FirstCall/ --...l company committed to,the discovery, development ...reatment of hepatitis and cancer, announced today ...inical development as an,orally-administered direc... C virus (HCV) infection. , "We have identified a ...
Other Medicine Technology:Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 2Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 3Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 4Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 5Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 6Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule,Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for,Clinical Development in Chronic Hepatitis C Virus Infection 2Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule,Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for,Clinical Development in Chronic Hepatitis C Virus Infection 3Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule,Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for,Clinical Development in Chronic Hepatitis C Virus Infection 4
Aire-Cuf® and Fome-Cuf® tracheostomy tubes with talk attachment are available in I.D. sizes from 5.0 mm to 9.5 mm. , ,Developed to aid the ventilator dependent patient in communicating with
For additional patient safety, the laryngectomy tube is designed with an integral 15 mm ISO termination that can be connected to a ventilator, with or without the inner cannula in place , ,Portex&re
The all silicone construction of the shaft and neck flange provides the utmost in patient comfort. , ,The Aire-Cuf® tracheostomy tube offers a more traditional and familiar air-filled cuff desig
...® Mid-Range Aire-Cuf® Adjustable Neck Flan...he TTS™ tube except this tube features the m...g;., ,Adult Mid-Range Aire-Cuf® Adjustable Ne...ude a trach tie, disconnect wedge, and obturator/i...
Medicine Products: